DK0822986T3 - Antagonister af human interleukin-6, der er fuldstændig ude af stand til at binde GP 130, og deres anvendelse til fremstilling af farmaceutiske forbindelser - Google Patents

Antagonister af human interleukin-6, der er fuldstændig ude af stand til at binde GP 130, og deres anvendelse til fremstilling af farmaceutiske forbindelser

Info

Publication number
DK0822986T3
DK0822986T3 DK96912205T DK96912205T DK0822986T3 DK 0822986 T3 DK0822986 T3 DK 0822986T3 DK 96912205 T DK96912205 T DK 96912205T DK 96912205 T DK96912205 T DK 96912205T DK 0822986 T3 DK0822986 T3 DK 0822986T3
Authority
DK
Denmark
Prior art keywords
human interleukin
antagonists
pct
bind
preparation
Prior art date
Application number
DK96912205T
Other languages
English (en)
Inventor
Gennaro Ciliberto
Rocco Savino
Giacomo Paonessa
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK0822986T3 publication Critical patent/DK0822986T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK96912205T 1995-04-28 1996-04-26 Antagonister af human interleukin-6, der er fuldstændig ude af stand til at binde GP 130, og deres anvendelse til fremstilling af farmaceutiske forbindelser DK0822986T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95RM000273A IT1276555B1 (it) 1995-04-28 1995-04-28 Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni
PCT/IT1996/000084 WO1996034104A1 (en) 1995-04-28 1996-04-26 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds

Publications (1)

Publication Number Publication Date
DK0822986T3 true DK0822986T3 (da) 2003-04-28

Family

ID=11403338

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96912205T DK0822986T3 (da) 1995-04-28 1996-04-26 Antagonister af human interleukin-6, der er fuldstændig ude af stand til at binde GP 130, og deres anvendelse til fremstilling af farmaceutiske forbindelser

Country Status (11)

Country Link
US (1) US5972902A (da)
EP (1) EP0822986B1 (da)
JP (2) JP3373856B2 (da)
AT (1) ATE233320T1 (da)
CA (1) CA2218372C (da)
DE (1) DE69626387T2 (da)
DK (1) DK0822986T3 (da)
ES (1) ES2191096T3 (da)
IT (1) IT1276555B1 (da)
PT (1) PT822986E (da)
WO (1) WO1996034104A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3824173B2 (ja) * 1995-11-07 2006-09-20 株式会社カネカ 自己抗原
WO1997029201A2 (de) * 1996-02-07 1997-08-14 Max-Delbrück-Centrum für Molekulare Medizin Retroviraler vektor für den gentransfer eines il6-antagonisten in humane hämatopoetische stammzellen
ATE547119T1 (de) 1997-03-21 2012-03-15 Chugai Pharmaceutical Co Ltd Präventives oder therapeutisches mittel mit einem il-6-antagonisten als wirkstoff für durch sensibilisierte t-zellen vermittelte erkrankungen
IT1291932B1 (it) * 1997-06-20 1999-01-21 Angeletti P Ist Richerche Bio Composizioni farmaceutiche antitumorali capaci anche di ridurre la farmacoresistenza in cellule tumorali, in particolare di carcinoma
KR100694005B1 (ko) 2000-03-06 2007-03-12 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. 높은 아로마타제 수준을 특징으로 하는 질병의 치료를위한 인터류킨-6 길항물질의 용도
KR20100120246A (ko) * 2001-11-14 2010-11-12 센토코 오르토 바이오테크 인코포레이티드 항 ｉｌ-6 항체, 조성물, 방법 및 용도
US20050100550A1 (en) * 2003-11-10 2005-05-12 Mohit Trikha Anti-angiogenic uses of IL-6 antagonists
ITRM20050103A1 (it) * 2005-03-10 2006-09-11 Rocco Savino Associazione di antagonisti della interleuchina 6 e farmaci antiproliferativi.
PE20061324A1 (es) 2005-04-29 2007-01-15 Centocor Inc Anticuerpos anti-il-6, composiciones, metodos y usos
US8188235B2 (en) 2008-06-18 2012-05-29 Pfizer Inc. Antibodies to IL-6 and their uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994009138A1 (en) * 1992-10-20 1994-04-28 Cetus Oncology Corporation Interleukin-6 receptor antagonists
IT1261787B (it) * 1993-06-23 1996-06-03 Angeletti P Ist Richerche Bio Metodologia per la selezione di superagonisti, antagonisti e super- antagonisti di ormoni del cui complesso recettoriale fa parte gp 130.

Also Published As

Publication number Publication date
ATE233320T1 (de) 2003-03-15
ITRM950273A1 (it) 1996-10-28
WO1996034104A1 (en) 1996-10-31
ITRM950273A0 (it) 1995-04-28
JPH10506538A (ja) 1998-06-30
DE69626387D1 (de) 2003-04-03
CA2218372A1 (en) 1996-10-31
IT1276555B1 (it) 1997-11-03
DE69626387T2 (de) 2003-12-11
JP2003153691A (ja) 2003-05-27
JP3373856B2 (ja) 2003-02-04
EP0822986B1 (en) 2003-02-26
EP0822986A1 (en) 1998-02-11
ES2191096T3 (es) 2003-09-01
US5972902A (en) 1999-10-26
PT822986E (pt) 2003-07-31
CA2218372C (en) 2001-07-31

Similar Documents

Publication Publication Date Title
DE60234616D1 (de) Substituierte piperidinen mit selektiver bindungsfähigkeit zu histamin h3-rezeptoren
NO20031179D0 (no) Chemokin-reseptorbindende heterocykliske forbindelser
DK0800519T3 (da) Steroidreceptormodulatorforbindelser og fremgangsmåder
DK0822986T3 (da) Antagonister af human interleukin-6, der er fuldstændig ude af stand til at binde GP 130, og deres anvendelse til fremstilling af farmaceutiske forbindelser
FI963101A (fi) Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoon, joissa seerumin interleukiini-6-taso on kohonnut
DK0751129T6 (da) Substituerede dihydrodibenzo(b,f)azepiner, fremgangsmåde til fremstilling deraf, deres anvendelse i behandlingen af nogle lidelser i centralnervesystemet og farmaceutiske sammensætninger indeholdende disse
TR199802423T2 (xx) Konsantre antikor terkibi.
ATE298248T1 (de) T-zell inhibierende rezeptorzusammensetzungen sowie deren verwendung
RU2009108149A (ru) Иммуноглобулины
TR199900318T2 (xx) IL-8 resept�r antagonistleri.
HK1068783A1 (en) Methods for increasing the therapeutic response to electroconvulsive therapy ("ect")
DK1141286T3 (da) Kæde af cytokinreceptorer
DK1063995T3 (da) Kombination til behandling af alkoholafhængighed indeholdende en opiod-antagonist og en NMDA-receptorkompleks-modulator
ATE357226T1 (de) (d)-methadon, ein nicht-opioides schmerzmittel
DE69228997D1 (de) Menschliche il-3-varianten
DK258789D0 (da) Peptider, der blokerer bindingen af hiv-1 til cd4 receptorproteinet
BG105761A (en) Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
DK0793721T3 (da) Peptider, der er i stand til at binde sig til GAP-proteinets SH3-domæne, nukleotidsekvenser, der koder derfor, fremstilling og anvendelse deraf
DE59809283D1 (de) Inhibitoren für den urokinaserezeptor
IL161296A0 (en) Glycosylphosphatidylinositol containing polypeptides
BR0010373A (pt) Uso de um agonista de cobre e método para identificação de um agonista de cobre
DE69434498D1 (de) Denervierende muskelkinase (dmk), ein rezeptor der tyrosinkinase-superfamilie
Martinez Senalizacion intracelular en la estimulacion de monocitos humanos por un peptido sintetico.
ITTO20010145A0 (it) Elemento di compensazione verso le differenze di massa e peso nei caschi.